Progression of lobaplatin for cancer
10.3760/cma.j.issn.1673-422X.2012.012.009
- VernacularTitle:洛铂治疗肿瘤的研究进展
- Author:
Na SUN
;
Wenyan YANG
- Publication Type:Journal Article
- Keywords:
Neoplasms;
Pharmacodynamics;
Clinical research;
Lobaplatin
- From:
Journal of International Oncology
2012;(12):907-909
- CountryChina
- Language:Chinese
-
Abstract:
Lobaplatin is the third generation platinum drug.Many studies on pharmacodynamics have confirmed that lobaplatin can block the cell cycle and induce cell apoptosis,and thus inhibits tumor cell proliferation effectively.Lobaplatin is not cross-resistant to cisplatin.Besides,it has good curative effect to various kinds of cancer patients with mild adverse reactions,and the patients are well tolerable to it.
